Invesco Dynamic Biotechnology & Genome ETF (PBE)
PBE is a passive ETF by Invesco tracking the investment results of the Dynamic Biotech & Genome Intellidex Index (AMEX). PBE launched on Jun 23, 2005 and has a 0.59% expense ratio.
ETF Info
| ISIN | US73935X8561 |
|---|---|
| CUSIP | 46137V787 |
| Issuer | Invesco |
| Inception Date | Jun 23, 2005 |
| Region | North America (U.S.) |
| Category | Health & Biotech Equities |
| Leveraged | 1x |
| Index Tracked | Dynamic Biotech & Genome Intellidex Index (AMEX) |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Growth |
Expense Ratio
PBE features an expense ratio of 0.59%, falling within the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: PBE vs. PJP, PBE vs. ARKG, PBE vs. IBB, PBE vs. IBBQ, PBE vs. BBH, PBE vs. IDNA, PBE vs. FBT, PBE vs. QQQ, PBE vs. XBI, PBE vs. IYH
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Invesco Dynamic Biotechnology & Genome ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Invesco Dynamic Biotechnology & Genome ETF had a return of 4.54% year-to-date (YTD) and 29.99% in the last 12 months. Over the past 10 years, Invesco Dynamic Biotechnology & Genome ETF had an annualized return of 3.50%, while the S&P 500 had an annualized return of 11.23%, indicating that Invesco Dynamic Biotechnology & Genome ETF did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 4.54% | 22.29% |
| 1 month | -1.45% | 1.65% |
| 6 months | 13.03% | 15.83% |
| 1 year | 29.99% | 39.98% |
| 5 years (annualized) | 6.21% | 13.99% |
| 10 years (annualized) | 3.50% | 11.23% |
Monthly Returns
The table below presents the monthly returns of PBE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.32% | 1.95% | -1.25% | -5.94% | 3.98% | 2.41% | 8.27% | 2.42% | -2.85% | 4.54% | |||
| 2023 | 5.17% | -4.73% | -1.34% | -0.28% | -3.67% | 1.66% | 3.53% | -2.98% | -7.35% | -6.04% | 9.34% | 12.36% | 3.71% |
| 2022 | -14.72% | -0.76% | 2.92% | -9.33% | 1.26% | 1.39% | 5.68% | -0.89% | -2.55% | 7.62% | 5.03% | -4.69% | -10.83% |
| 2021 | 7.92% | -2.00% | -0.47% | 2.17% | -2.92% | 5.61% | -2.50% | 4.10% | -4.65% | 0.31% | -6.10% | 1.03% | 1.54% |
| 2020 | -3.25% | -7.27% | -7.14% | 14.54% | 8.99% | 0.39% | 1.26% | -0.56% | -3.50% | -0.14% | 12.99% | 9.77% | 25.66% |
| 2019 | 11.64% | 4.32% | 0.67% | -5.43% | -7.25% | 10.56% | -1.10% | -5.54% | -5.25% | 7.72% | 8.44% | 0.92% | 18.65% |
| 2018 | 10.54% | -1.84% | -3.81% | -2.32% | 7.03% | 6.32% | 5.03% | 4.47% | -0.96% | -13.80% | 3.42% | -11.19% | -0.19% |
| 2017 | 5.00% | 7.07% | -2.95% | 1.92% | -2.99% | 9.78% | 1.97% | 4.70% | 2.40% | -6.63% | -0.99% | 2.17% | 22.28% |
| 2016 | -23.73% | -4.33% | 3.85% | 2.72% | 3.51% | -9.12% | 11.38% | -2.52% | 4.53% | -10.92% | 9.02% | -4.46% | -22.90% |
| 2015 | 5.52% | 3.49% | 0.58% | -3.97% | 9.17% | 1.15% | 1.93% | -9.93% | -14.45% | 9.40% | 1.94% | -0.30% | 1.72% |
| 2014 | 13.25% | 7.60% | -7.80% | -4.66% | -0.76% | 11.56% | -1.65% | 11.14% | -3.18% | 7.94% | 1.74% | -1.10% | 36.34% |
| 2013 | 8.60% | -0.32% | 6.07% | 7.93% | 5.41% | -3.16% | 13.15% | 0.70% | 6.53% | 0.29% | 8.05% | -2.50% | 62.24% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PBE is 34, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Invesco Dynamic Biotechnology & Genome ETF provided a 0.05% dividend yield over the last twelve months, with an annual payout of $0.03 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.03 | $0.01 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.27 | $0.15 | $0.57 | $0.28 |
Dividend yield | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% | 0.55% |
Monthly Dividends
The table displays the monthly dividend distributions for Invesco Dynamic Biotechnology & Genome ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 | ||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2017 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.22 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.27 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.12 | $0.15 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.31 | $0.57 |
| 2014 | $0.23 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.28 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Invesco Dynamic Biotechnology & Genome ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Invesco Dynamic Biotechnology & Genome ETF was 45.69%, occurring on Mar 9, 2009. Recovery took 407 trading sessions.
The current Invesco Dynamic Biotechnology & Genome ETF drawdown is 17.85%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -45.69% | Oct 16, 2007 | 351 | Mar 9, 2009 | 407 | Oct 18, 2010 | 758 |
| -44.56% | Jul 20, 2015 | 238 | Jun 27, 2016 | 1022 | Jul 20, 2020 | 1260 |
| -37.84% | Feb 9, 2021 | 340 | Jun 14, 2022 | — | — | — |
| -26.36% | May 13, 2011 | 60 | Aug 8, 2011 | 227 | Jul 2, 2012 | 287 |
| -21.12% | Feb 28, 2006 | 97 | Jul 17, 2006 | 192 | Apr 23, 2007 | 289 |
Volatility
Volatility Chart
The current Invesco Dynamic Biotechnology & Genome ETF volatility is 4.63%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.